• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET 360 NANO 1MM X 2CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET 360 NANO 1MM X 2CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Catalog Number M0035421020
Medical Device Problem Code Migration (4003)
Health Effect - Clinical Codes Foreign Body In Patient (2687); Device Embedded In Tissue or Plaque (3165); Ruptured Aneurysm (4436)
Date of Event 08/15/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H3 other text : the device remains in the patient.
 
Event or Problem Description
It was reported post the pcom aneurysm procedure, the subject coil mass dislodged from the treatment site resulting in aneurysm re-rupture.The coil mass was not attempted to be removed and remains in the patients m1.The current condition of the patient is unknown.No further information is available.
 
Event or Problem Description
It was reported post the pcom aneurysm procedure, the subject coil mass dislodged from the treatment site resulting in aneurysm re-rupture.The coil mass was not attempted to be removed and remains in the patients m1.The current condition of the patient is unknown.No further information is available.Additional information received on the 28 sep 2023 from the complaint intake center clarified that the treatment occurred because of the aneurysm re-rupture and it was months after initial coil treatment that the aneurysm re-rupture occurred.The coil migration occurred hours after the treatment for the aneurysm re-rupture.Therefore the coil mass dislodging from the treatment site did not result in aneurysm re-rupture.
 
Additional Manufacturer Narrative
There are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, visual and functional testing as well as physical analysis cannot be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.Additional information provided by the customer stated the coil migration occurred hours after the aneurysm treatment and there is no indication of any issues reported during the procedure.While there are a number of potential causes for the reported issue, because review and analysis of available information failed to identify a definitive cause and the device was not returned, an assignable cause of undeterminable will be assigned to this complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET 360 NANO 1MM X 2CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key17690980
Report Number3008881809-2023-00453
Device Sequence Number15081293
Product Code HCG
UDI-Device Identifier04546540697967
UDI-Public04546540697967
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K153658
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberM0035421020
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/16/2023
Supplement Date Received by Manufacturer09/29/2023
Initial Report FDA Received Date09/06/2023
Supplement Report FDA Received Date10/19/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age75 YR
Patient SexFemale
-
-